M. Anderson

Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation.

R. Makuch, J. Minna, J. Minna, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patterns of Failure Observed in the 2-Step Institution Credentialing Process for NRG Oncology/Radiation Therapy Oncology Group 1005 (NCT01349322) and Lessons Learned

F. Vicini, M. Lock, Ying Xiao, 2020 .

Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years.

S. Steinberg, J. Mulshine, B. Johnson, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Wait times for diagnosis and treatment of lung cancer: a single-centre experience.

Y. Lacasse, S. Simard, L. Tremblay, 2017, Current oncology.

Long-term Overall Survival Outcomes in Patients with Early Stage, Peripherally Located, Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy in a Non-academic Cancer Centre.

J. Daniel, C. Peedell, K. Burke, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

Severe lymphopenia was associated with reduced overall survival and progression-free survival among the Hispanic women who underwent definitive chemoradiation therapy for cervical cancer, but not with the outcomes among the non-Hispanic women. Keywords: Cervical cancer; Chemoradiotherapy; Anemia; Ly

M. Anderson, Shi F, A. Yoder, 2022 .

Satisfaction with the decision to participate in cancer clinical trials is high, but understanding is a problem

M. Jefford, L. Mileshkin, T. Cavicchiolo, 2011, Supportive Care in Cancer.

986ORANDOMIZED PHASE II STUDY OF MEHD7945A (MEHD) VS CETUXIMAB (CET) IN >= 2ND-LINE RECURRENT/METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD & NECK (RMSCCHN) PROGRESSIVE ON/AFTER PLATINUM-BASED CHEMOTHERAPY (PTCT).

A. Jimeno, P. Harari, C. Nutting, 2014, Annals of Oncology.

Effect of adjuvant zoledronic acid (ZOL) on disseminated tumor cells (DTC) in the bone marrow (BM) of women with early-stage breast cancer (ESBC): Updated results.

M. Moasser, A. Goga, John W. Park, 2010 .